Pagaya Upgrade: Caution Warranted Despite Undervaluation Claims

What happened

A Seeking Alpha article upgrades Pagaya Technologies to a buy, arguing that the stock is undervalued despite the company overstating its AI-driven underwriting capabilities and raising concerns about management credibility. However, the DeepValue master report maintains a WAIT rating, emphasizing that Pagaya's profitability record remains short and should not be treated as through-the-cycle proof, with key risks including the retained investment portfolio and large credit-loss allowance. Recent operational progress is acknowledged, but the report highlights that negative capital markets execution fees and a one-time allowance for credit losses addition signal persistent spread pressure and credit risk. The market narrative is cautiously optimistic, but the thesis hinges on observable proof of positive unit economics, specifically positive execution fees and stable credit reserves. Until these conditions are met in an upcoming quarterly filing, the stock remains a show-me story with downside risks toward $7 and upside toward $18.

Implication

The upgrade suggests improved sentiment, but the DeepValue report's WAIT rating is prudent given the lack of through-the-cycle proof and persistent risks from spread pressure and credit loss allowance. The key risk is that negative execution fees and rising reserves will continue to compress EBITDA, potentially driving the stock toward the $7 bear case. Conversely, if ABS execution strengthens with broad investor participation and forward-flow facilities are utilized, the stock could re-rate toward the $18 bull case. The next quarterly filing will be decisive: positive execution fees and stable reserves would justify an upgrade, while further deterioration would confirm the bear thesis. Until then, position sizing must assume a capital markets-driven drawdown remains a base-rate scenario.

Thesis delta

The thesis shifts from outright skepticism of the business model to a cautious wait-and-see approach, as the article's upgrade suggests the stock may have priced in many risks. However, the fundamental threshold for moving from WAIT to BUY remains unmet: the next quarter must show positive execution fees and no further credit reserve expansion. The delta is that the market may be turning more positive, but the core risk of spread-driven fee compression still dominates the near-term outlook.